Last reviewed · How we verify

Ammoniated Mercury — Competitive Intelligence Brief

Ammoniated Mercury (mercuric amidochloride) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: mercuric amidochloride. Area: Infectious Disease.

unknown mercuric amidochloride Infectious Disease Live · refreshed every 30 min

Target snapshot

Ammoniated Mercury (mercuric amidochloride). Ammoniated Mercury is thought to work by exerting a local antimicrobial effect, although the exact mechanism is not well understood.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ammoniated Mercury TARGET mercuric amidochloride unknown mercuric amidochloride

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (mercuric amidochloride class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ammoniated Mercury — Competitive Intelligence Brief. https://druglandscape.com/ci/mercuric-amidochloride. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing